117 related articles for article (PubMed ID: 24343902)
21. Inhibition of ultraviolet B-induced AP-1 activation by theaflavins from black tea.
Nomura M; Ma WY; Huang C; Yang CS; Bowden GT; Miyamoto K; Dong Z
Mol Carcinog; 2000 Jul; 28(3):148-55. PubMed ID: 10942531
[TBL] [Abstract][Full Text] [Related]
22. Synergistic activation of the tumor suppressor, HLJ1, by the transcription factors YY1 and activator protein 1.
Wang CC; Tsai MF; Dai TH; Hong TM; Chan WK; Chen JJ; Yang PC
Cancer Res; 2007 May; 67(10):4816-26. PubMed ID: 17510411
[TBL] [Abstract][Full Text] [Related]
23. Blockade of AP-1 activity by dominant-negative TAM67 can abrogate the oncogenic phenotype in latent membrane protein 1-positive human nasopharyngeal carcinoma.
Jin X; Song X; Li L; Wang Z; Tao Y; Deng L; Tang M; Yi W; Cao Y
Mol Carcinog; 2007 Nov; 46(11):901-11. PubMed ID: 17477349
[TBL] [Abstract][Full Text] [Related]
24. Interleukin-17 induces AP-1 activity and cellular transformation via upregulation of tumor progression locus 2 activity.
Kim G; Khanal P; Lim SC; Yun HJ; Ahn SG; Ki SH; Choi HS
Carcinogenesis; 2013 Feb; 34(2):341-50. PubMed ID: 23125217
[TBL] [Abstract][Full Text] [Related]
25. The c-Jun NH(2)-terminal protein kinase/AP-1 pathway is required for efficient apoptosis induced by vinblastine.
Fan M; Goodwin ME; Birrer MJ; Chambers TC
Cancer Res; 2001 Jun; 61(11):4450-8. PubMed ID: 11389075
[TBL] [Abstract][Full Text] [Related]
26. [Transcription of c-fos gene and DNA binding activity of transcription factor AP-1 increase upon differentiation of mouse F9 teratocarcinoma cells].
Chuĭkin IA; Lianguzova MS; Pospelov VA
Tsitologiia; 2004; 46(12):1080-90. PubMed ID: 15747838
[TBL] [Abstract][Full Text] [Related]
27. A peptide fragment of ependymin neurotrophic factor uses protein kinase C and the mitogen-activated protein kinase pathway to activate c-Jun N-terminal kinase and a functional AP-1 containing c-Jun and c-Fos proteins in mouse NB2a cells.
Adams DS; Hasson B; Boyer-Boiteau A; El-Khishin A; Shashoua VE
J Neurosci Res; 2003 May; 72(3):405-16. PubMed ID: 12692907
[TBL] [Abstract][Full Text] [Related]
28. Identification of a novel SP3 binding site in the promoter of human IGFBP4 gene: role of SP3 and AP-1 in regulating promoter activity in CaCo2 cells.
Shen Q; Singh P
Oncogene; 2004 Apr; 23(14):2454-64. PubMed ID: 14767471
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of AP-1 transcription factor causes blockade of multiple signal transduction pathways and inhibits breast cancer growth.
Liu Y; Ludes-Meyers J; Zhang Y; Munoz-Medellin D; Kim HT; Lu C; Ge G; Schiff R; Hilsenbeck SG; Osborne CK; Brown PH
Oncogene; 2002 Oct; 21(50):7680-9. PubMed ID: 12400010
[TBL] [Abstract][Full Text] [Related]
30. Silica-induced TNF-alpha and TGF-beta1 expression in RAW264.7 cells are dependent on Src-ERK/AP-1 pathways.
Li X; Hu Y; Jin Z; Jiang H; Wen J
Toxicol Mech Methods; 2009 Jan; 19(1):51-8. PubMed ID: 19778233
[TBL] [Abstract][Full Text] [Related]
31. Signal transduction pathways: targets for green and black tea polyphenols.
Park AM; Dong Z
J Biochem Mol Biol; 2003 Jan; 36(1):66-77. PubMed ID: 12542977
[TBL] [Abstract][Full Text] [Related]
32. Up-regulation of TRPM6 transcriptional activity by AP-1 in renal epithelial cells.
Ikari A; Sanada A; Okude C; Sawada H; Yamazaki Y; Sugatani J; Miwa M
J Cell Physiol; 2010 Mar; 222(3):481-7. PubMed ID: 19937979
[TBL] [Abstract][Full Text] [Related]
33. Transition from SCLC to NSCLC phenotype is accompanied by an increased TRE-binding activity and recruitment of specific AP-1 proteins.
Risse-Hackl G; Adamkiewicz J; Wimmel A; Schuermann M
Oncogene; 1998 Jun; 16(23):3057-68. PubMed ID: 9662339
[TBL] [Abstract][Full Text] [Related]
34. Effect of 1-beta-D-arabinofuranosylcytosine on apoptosis and differentiation in human monocytic leukemia cells (U937) expressing a c-Jun dominant-negative mutant protein (TAM67).
Grant S; Freemerman AJ; Birrer MJ; Martin HA; Turner AJ; Szabo E; Chelliah J; Jarvis WD
Cell Growth Differ; 1996 May; 7(5):603-13. PubMed ID: 8732670
[TBL] [Abstract][Full Text] [Related]
35. Curcumin inhibits lung cancer cell invasion and metastasis through the tumor suppressor HLJ1.
Chen HW; Lee JY; Huang JY; Wang CC; Chen WJ; Su SF; Huang CW; Ho CC; Chen JJ; Tsai MF; Yu SL; Yang PC
Cancer Res; 2008 Sep; 68(18):7428-38. PubMed ID: 18794131
[TBL] [Abstract][Full Text] [Related]
36. Anticancer activity of Phyllanthus emblica Linn. (Indian gooseberry): inhibition of transcription factor AP-1 and HPV gene expression in cervical cancer cells.
Mahata S; Pandey A; Shukla S; Tyagi A; Husain SA; Das BC; Bharti AC
Nutr Cancer; 2013; 65 Suppl 1():88-97. PubMed ID: 23682787
[TBL] [Abstract][Full Text] [Related]
37. Alternative pathway of transcriptional induction of p21WAF1/Cip1 by cyclosporine A in p53-deficient human glioblastoma cells.
Zupanska A; Adach A; Dziembowska M; Kaminska B
Cell Signal; 2007 Jun; 19(6):1268-78. PubMed ID: 17321721
[TBL] [Abstract][Full Text] [Related]
38. MAPK/AP-1 signal pathway in tobacco smoke-induced cell proliferation and squamous metaplasia in the lungs of rats.
Zhong CY; Zhou YM; Douglas GC; Witschi H; Pinkerton KE
Carcinogenesis; 2005 Dec; 26(12):2187-95. PubMed ID: 16051644
[TBL] [Abstract][Full Text] [Related]
39. Combined inhibitory effects of green tea polyphenols and selective cyclooxygenase-2 inhibitors on the growth of human prostate cancer cells both in vitro and in vivo.
Adhami VM; Malik A; Zaman N; Sarfaraz S; Siddiqui IA; Syed DN; Afaq F; Pasha FS; Saleem M; Mukhtar H
Clin Cancer Res; 2007 Mar; 13(5):1611-9. PubMed ID: 17332308
[TBL] [Abstract][Full Text] [Related]
40. Physical and functional cooperation between AP-1 and beta-catenin for the regulation of TCF-dependent genes.
Toualbi K; Güller MC; Mauriz JL; Labalette C; Buendia MA; Mauviel A; Bernuau D
Oncogene; 2007 May; 26(24):3492-502. PubMed ID: 17146436
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
